Development of an advance directive 'communication tool' relevant for patients with advanced cancer in six European countries: Experiences from the ACTION trial.
Caroline Moeller ArnfeldtMogens GroenvoldAnna Thit JohnsenBranka ČervLuc DeliensLesley DunleavyAgnes van der HeideMarijke C KarsUrška LunderGuido MiccinesiKristian PollockJudith A C RietjensJane Seymournull nullPublished in: PloS one (2022)
This article shows the complex task of developing an advance directive suitable for cancer patients from six European countries; a process which required the resolution of several cross cultural differences in law, ethics, philosophy and practice. Our hope is that this paper can contribute to a deeper conceptual understanding of advance directives, their role in supporting decision making among patients approaching the end of life and be an inspiration to others wishing to develop a disease-specific advance directive or a standardised multinational advance directive.